When cancer cells break off from their initial tumour they can spread throughout the body and invade other organs to form new tumours, in a process known as metastasis. Metastatic tumours cause patients to develop stage IV or advanced cancer and are responsible for over 90% of deaths in cancer patients. In the past, cancer […]
It’s estimated that 90% of cancer patients that die from their disease die from cancer metathesis. Despite this, there are currently no therapies in the market that tackle the mechanisms of metastasis and less than 5% of cancer funds go towards tackling metastatic cancer. That’s a dire situation for cancer patients and their families, and […]
A rare and difficult to cure bone cancer in children has been found to have significant genetic similarities with the same type of cancer in dogs. This insight could improve understanding of the disease and lead the development of more effective treatments. Osteosarcoma (OS) is a rare bone cancer in children, but relatively common in […]
Yale University researchers have discovered a potential new biomarker for identifying individuals with increased risk of prostate cancer metastasis. The findings announced that mitochondrial protein syntaphilin is vital in determining the balance between tumour cell proliferation and tumour cell invasion, and is expressed significantly at the invasive tumour edge in prostate cancer.
Swiss scientists have found a potential new way to block metastasis, with promising results demonstrated in mice. The researchers have found a “barrier”, built by the Activin B protein and a receptor called ALK7, the combo of which prevents tumours from spreading through the body.